Home/Filings/4/0001140361-25-034934
4//SEC Filing

MANCHESTER KEITH S 4

Accession 0001140361-25-034934

CIK 0001635088other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 9:00 PM ET

Size

7.3 KB

Accession

0001140361-25-034934

Insider Transaction Report

Form 4
Period: 2025-09-10
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-09-10+33,72633,726 total
    Exercise: $13.77Exp: 2035-09-09Common Shares (33,726 underlying)
  • Award

    Common Shares

    2025-09-10+14,5241,948,403 total
Footnotes (2)
  • [F1]Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date.
  • [F2]Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date.

Issuer

Roivant Sciences Ltd.

CIK 0001635088

Entity typeother

Related Parties

1
  • filerCIK 0001244828

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 9:00 PM ET
Size
7.3 KB